“fda” Archives

in
Entry Author Date Location
Bio Roundup: Mylan Grilled, Duchenne Kids Thrilled, Zuck-Chan & More 09/23/16 National
Progenerative Plans Bone, Business Growth From Revived Acelity Tech 09/22/16 Texas
Sarepta Preps For Sales As Insurers Unlikely To Deny Duchenne Drug 09/22/16 Boston
Regeneron, in Pain Drug Race With Pfizer & Lilly, Gets $250M From Teva 09/20/16 New York
Sarepta Prices $300K Duchenne Drug As FDA Rift Emerges Over Approval 09/19/16 Boston
After New Data, FDA Bucks Advisory Panel, Approves Sarepta’s Duchenne Drug 09/19/16 Boston
Biotech Roundup: CRISPR’s 3rd IPO, Gender Diversity, Buyouts & More 09/16/16 National
For Fledgling San Antonio Companies, Startup Resources Trickling In 09/13/16 Texas
HealthMyne Brings On New CEO, Eyes 2017 For Commercial Launch 09/12/16 Wisconsin
Chrono Therapeutics Scores $47.6M to Advance Anti-Smoking System 09/09/16 San Francisco
Retrophin Drug Licensed by Shkreli Shows Positive Phase 2 Results 09/07/16 San Diego
Celgene Plots Speedy FDA Filing for Agios Blood Cancer Drug 09/07/16 Boston
Immunotherapy Clinical Tests Spur Hope, and Plenty of Headaches 09/07/16 National
Bio Roundup: RIP Roger Tsien, Novartis CAR-T Wheel, Zika News & More 09/02/16 National
Novartis Disbands T Cell Group But Promises To Press Ahead In CAR-T Race 08/31/16 National
Path Cleared for Bluegrass Vascular’s Vein-Access Device in Europe 08/30/16 Texas
Denise Pierce on Growth in Indiana’s Life Sciences Industry 08/26/16 Indiana
Bio Roundup: Mylan’s Shock, Hillary’s 3%, Duchenne Lessons & More 08/26/16 National
Duchenne Lessons: Advocates For Rare Spinal Disease Have Eyes on FDA 08/26/16 National
Novan Files for IPO to Finance ‘Nitric Oxide on Demand’ Skin Drugs 08/25/16 Raleigh Durham
Pfizer Shells Out $14B to Win Medivation Sweepstakes 08/22/16 San Francisco
Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More 08/19/16 National
Imbed Biosciences Nabs $600K For Infection-Preventing Wound Dressing 08/18/16 Wisconsin
Epic, Wellbe, WARF, & Arrowhead: This Week’s Wisconsin Watchlist 08/17/16 Wisconsin
Rare Drug Developer Chiasma Lays Off More Workers After FDA Impasse 08/16/16 Boston
OncoGenex Hires Advisor, Evaluates Options As Cancer Drug Fails Again 08/16/16 Seattle
Stratatech, Maker of Skin-Like Tissue, To Be Sold To Mallinckrodt 08/12/16 Wisconsin
Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More 08/12/16 National
Heron Gains FDA Support For Nausea Drug After A Year Under Review 08/10/16 San Francisco
EyeKor Stares Down $600K to Develop Clinical Trial Software 08/09/16 Wisconsin
Page 1 of 54 next page »